1Evan G, Littlewood T. A matter of life and cell death[J].Science, 1998, 28:1317-1322.
2Ver AM J, Bringuier PP, Schaafasma HE, et al. Comparision of p53 protein overexpression with p53 mutation in bladder cancer : clinical and biologic aspects [J ]. Lab Invest, 1995,73 :837-843.
3Nakopoulou L, Constantinides C, Papandropoulis J 0 et al. Evaluation of overexpression of P53 tumors suppressor protein in superficial and invasive transitional cell bladder cancer :comparision with DNA ploidy[J]. Urology, 1995,46:334-343.
4Sioblom T, Shimizu A, O'Brien KP, et al. Growth inhibition of dermatofibrosarcoma protuberans tumors by the platelet-de-rived growth factor receptor antagonist STI571 through induction of apoptosis[J]. Cancer Res, 2001 , 61(15) : 5778-5783.
5Lu QL, Abel P, Foster CS, et al. Bcl-2: Role in epithelial differentiation and oncogenesis[J]. Hum Pathol, 1996, 27(2) : 102-110.
6Yang E, Korsmeyer SJ. Molecular thanatopsis: A discourse on the Bcl-2 family and cell death[J]. Blood, 1996, 88(2):386-401.
7Tsujimoto Y, Finger LR,Yunis J, et al. Cloning of the chromosome breakpoint of neoplastic B cells with the t (14; 18)chromosome translocation[J]. Science, 1984, 226: 1097-1099.
8Lin EY, Orlofrky A, Wang HG, et al. A1, Bcl-2 family member, prolongs cell survival and permits myeloid differentiation[J]. Blood, 1996, 87(3): 983-992.
9Verhaegh MEJM, Sanders CJG, Arends JW, et al. Expression of apoptosis-suppressing protein Bcl-2 in nonmelanlma skin cancer[J]. Br J Dermatol, 1995, 132(5):740-744.
10Griffith TS, Brunner T, Fletcher SM, et al. Fas ligand-in-duced apoptosis as a mechanism of immune privilege[J]. Science, 1995, 270:1189-1192.
9Litvak DA,Bilcbik AF,Cabot MC.Modulators of ceramide metabolism sensitize colorectal cancer cells to chemotherapy:A novel treatment strategy[J].J Gastrointest Surg,2003,7(12):140-148.
10Dharap SS,Qiu B,Williams GC.Molecular targeting of drug delivery systems to ovarian cancer by BH3 and LHRH peptides[J].Journal of Controlled Release,2003,91(10):61-73.
